Qrxpharma Limited
Records under this name other than patents Qrxpharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Qrxpharma Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,012,990 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia Lapsed on the fee record Ended Sep 6, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 6, 2019 | From the USPTO record |
| US 7,070,969 | Plasmin Inhibitors from the Australian Brown Snake Pseudonaja Textilis Textilis Formerly held Term ended Term ended May 7, 2019 · High confidence | Term ended | Term ended May 7, 2019 | High confidence |
| US 7,923,453 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia Lapsed on the fee record Ended Apr 12, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 12, 2019 | From the USPTO record |
| US 8,933,092 | Methods and compositions comprising sequential administration opioid receptor agonists Lapsed on the fee record Ended Jan 13, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 13, 2019 | From the USPTO record |
| US 8,461,171 | Hybrid opioid compounds and compositions Lapsed on the fee record Ended Jun 11, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2017 | From the USPTO record |
| US 8,222,267 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia Lapsed on the fee record Ended Jul 17, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2016 | From the USPTO record |
| US 8,182,837 | Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness Lapsed on the fee record Ended May 22, 2016 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2016 | From the USPTO record |